Dr. Michael Joseph Madigan Jr., MD

Dr. Madigan practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Madigan's NPI, 1194245167, was assigned on June 21, 2017. Dr. Madigan graduated from Washington University School of Medicine in 2017. Dr. Madigan holds North Carolina license 2023-00037.

Dr. Madigan's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Madigan's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Madigan is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Madigan to 4 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madigan practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Madigan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Madigan's licenses on file in 2 states: North Carolina and Missouri.

CMS data shows 475 Medicare services from Dr. Madigan across 14 procedure codes in 2024, for 321 Medicare patients. Medicare paid $22,138 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 321 Medicare patients who saw Dr. Madigan in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Madigan's median patient age at 72, with 48% women.

In 2024, Dr. Madigan wrote 691 Medicare Part D claims for 138 patients. 84% of them were for generic drugs. CMS names the drug for 592 of them, across 15 drugs with 11 or more claims each, at $93,493 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

Dr. Madigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Madigan, published from 2019 to 2022. The most frequent topics are Heart and Myocardium. Dr. Madigan's most frequent co-authors are Amrish Deshmukh, MD, Robert J. Gropler, MD and Jackson Jeikai Liang, DO.

Dr. Madigan graduated from Washington University School of Medicine in 2017.